Ronald H. Carlson
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Ronald H. Carlson
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 15 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Ronald H. Carlson tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member | |
BIOLASE, INC. | Medical Specialties | Director of Finance/CFO | |
GENVEC INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pervasis Therapeutics, Inc.
Pervasis Therapeutics, Inc. Medical SpecialtiesHealth Technology Pervasis Therapeutics, Inc. is a clinical stage company developing a broad portfolio of biologically active therapeutics. The company was founded by Robert S. Langer Jr. and Helen Marie Nugent in 2004 and is headquartered in Waltham, MA. | Medical Specialties | Director/Board Member | |
ENERGY RECOVERY, INC. | Industrial Machinery | Comptroller/Controller/Auditor | |
CereHealth Corp.
CereHealth Corp. Medical/Nursing ServicesHealth Services CereHealth Corp. engages in the production of brain imaging software by utilizing high resolution gamma cameras. It specializes in Single-Photon Emission Computed Tomography (SPECT) & Positron Emission Tomography (PET). The company is headquartered in Littleton, CO. | Medical/Nursing Services | Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Masters Business Admin | |
Covington & Burling LLP
Covington & Burling LLP Miscellaneous Commercial ServicesCommercial Services Covington & Burling LLP provides legal services. It also provides support services in the following administrative departments including accounting, human resources, information research services, information technology services, library, operations, marketing, practice systems support, recruitment, attorney and alumni relations, and professional development. The company was founded by J. Harry Covington and Edward B. Burling on January 1, 1919 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | General Counsel | |
Florida State University | College/University | Undergraduate Degree | |
Golden Gate University | College/University | Masters Business Admin Masters Business Admin | |
Gustavus Adolphus College | College/University | Undergraduate Degree | |
Yale University | College/University | Undergraduate Degree | |
University of California, Davis | College/University | Undergraduate Degree | |
University of Nevada
University of Nevada Other Consumer ServicesConsumer Services University of Nevada functions as a college and university. It provides education, research, scholarship, creative activities, and clinical services. The company was founded on September 10, 1957 and is headquartered in Las Vegas, NV. | College/University | Undergraduate Degree | |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American Society For Quality, Inc.
American Society For Quality, Inc. Miscellaneous Commercial ServicesCommercial Services American Society For Quality, Inc. engages in promoting and advancing quality tools, principles and practices in their workplaces and communities. The company is headquartered in Milwaukee, WI. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
International Society for Pharmaceutical Engineering
International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Parenteral Drug Association | Corporate Officer/Principal | ||
Critical Path Institute
Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
Kearny Venture Partners
Kearny Venture Partners Investment ManagersFinance Kearny Venture Partners (Kearny Venture Partners) is a venture capital firm. The firm is headquartered in San Francisco, California. | Investment Managers | Consultant / Advisor | |
Red.com LLC
Red.com LLC Electronic Equipment/InstrumentsElectronic Technology Red.com, Inc. is a leading manufacturer of professional digital cinema cameras. The company was founded in 1999 and is based in Irvine, CA with subsidiaries in the United States. The company offers a modular camera system and groundbreaking image quality, including compact cinema cameras with unparalleled image quality and color science. Red.com also opened a studio to change the industry standard and help create the future of filmmaking. The company believes in personalizing the experience for each production and are committed to challenging convention and making an impact. Additionally, they offer real-world training on cameras and equipment taught by industry experts for both students and working professionals alike. | Electronic Equipment/Instruments | Comptroller/Controller/Auditor | |
MMRGLOBAL, INC. | Information Technology Services | Director/Board Member | |
Institute For Health Policy Analysis, Inc. | Director/Board Member | ||
RAPTOR PHARMACEUTICAL CORP | Pharmaceuticals: Major | Corporate Officer/Principal | |
KITE PHARMA INC | Biotechnology | Corporate Officer/Principal | |
Claremont College | College/University | Director/Board Member | |
Life Line Screening Holdings LLC
Life Line Screening Holdings LLC Medical/Nursing ServicesHealth Services Life Line Screening Holdings LLC is a private company that provides annual screenings for risks of cardiovascular disease, stroke, and other chronic diseases. The company is based in Austin, TX. The company's screenings are designed by doctors and administered by trained professionals to help detect hidden health issues before they become a serious problem. The company offers a high sensitivity c-reactive protein test (hs-crp test) to detect inflammation in the body, which can indicate the presence of atherosclerosis. The company also provides type 2 diabetes test and diagnosis services. The company was founded in 1993 and the CEO is Matt Miller. | Medical/Nursing Services | Director/Board Member | |
RNA Therapeutics Institute | Director/Board Member | ||
RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member | |
KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Pendulum Therapeutics, Inc.
Pendulum Therapeutics, Inc. BiotechnologyHealth Technology Pendulum Therapeutics, Inc. engages in the development of therapeutics and diagnostics that target the human microbiome to improve the lives of patients suffering from various diseases. Its product pipeline includes WBF-011, WBF-020, WBF-012, and WBF-014.. The company was founded by Colleen Cutcliffe, John Eid, and James Bullard in 2012 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Epiva Biosciences, Inc.
Epiva Biosciences, Inc. BiotechnologyHealth Technology Epiva Biosciences, Inc. develops immunobiotic therapeutics. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Proterris, Inc.
Proterris, Inc. Pharmaceuticals: MajorHealth Technology Proterris, Inc. manufactures applications of low-dose carbon monoxide. It develops carbon monoxide for delayed graft function in renal transplant recipients and idiopathic pulmonary fibrosis. The company was founded by Jeffrey Wager and Joseph Wager and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Placon Therapeutics, Inc.
Placon Therapeutics, Inc. BiotechnologyHealth Technology Placon Therapeutics, Inc. develops novel platinum therapies. The private company is based in Watertown. | Biotechnology | Director/Board Member | |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
MODERNA, INC. | Biotechnology | Director/Board Member | |
Seventh Sense, Inc. | Director/Board Member | ||
The Academy of Food Law & Policy, Inc. | Director/Board Member | ||
Colabs International Corp.
Colabs International Corp. Pharmaceuticals: MajorHealth Technology Colabs International Corp. is a pharmaceutical company that develops formulations and medicines. The company’s targeted epidermal-drug delivery system which is identified as QuantaSphere Technology for cosmeceuticals, fragrances, antibacterial, anti-viral sanitizers, cleaners, and topical pharmacology. It also offers sunscreen, pest repellents, and sanitizers, soap distribution for the firm’s Klenskin products internationally. Its QuantaSphere Technology formulations provide proprietary, epidermal therapeutic effects and also blends consumer needs for a healthy lifestyle with targeted, eco-friendly, multi-tasking products. The company was founded by Laura Cohen and Lisa Leblanc on August 5, 2008 and is headquartered in Huntington Beach, CA. | Pharmaceuticals: Major | Director/Board Member | |
ImmuneID, Inc.
ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Atelerix Life Sciences, Inc.
Atelerix Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Atelerix Life Sciences, Inc. is a pharmaceutical company that is developing a new drug, ATLX-0199, to address the unmet need of opioid-induced respiratory depression (OIRD) in surgical patients. The company is based in Charlottesville, VA. Atelerix Life Sciences was founded by David G. Kalergis, Benjamin Gaston, James Bates, and Stephen Lewis, with David G. Kalergis serving as the CEO since incorporation. The current drug for OIRD, Naloxone, is problematic and used infrequently because it reverses pain relief. ATLX-0199 safely stimulates opioid-depressed respiratory drive without interfering with opioid-induced analgesia. | Pharmaceuticals: Major | Director/Board Member | |
Solu Therapeutics
Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 48 |
Francia | 2 |
Australia | 2 |
Canada | 2 |
Settori
Health Technology | 22 |
Consumer Services | 9 |
Commercial Services | 8 |
Health Services | 3 |
Industrial Services | 2 |
Posizioni
Director/Board Member | 81 |
Corporate Officer/Principal | 27 |
Private Equity Investor | 18 |
Independent Dir/Board Member | 16 |
Undergraduate Degree | 14 |
Contatti più connessi
Insiders | |
---|---|
Peter Hutt | 69 |
Patrick Zenner | 24 |
Phillip Young | 24 |
Marvin J. Garrett | 11 |
Charles C. Wells | 10 |
J. Boyle | 9 |
Peter B. Davis | 8 |
Daniel J. Gennevois | 7 |
Marilyn A. Lobel | 7 |
Marc D. Better | 7 |
Calvin L. McGoogan | 6 |
Patrick Rivers | 6 |
Clarence L. Dellio | 5 |
Robert S. Tenerowicz | 4 |
Patricia Donahue | 4 |
- Borsa valori
- Insiders
- Ronald H. Carlson
- Connessioni Società